Community Leaders Resilience Fund
Sustaining leaders in service to people and planet, reducing the financial and logistical barriers to accessing legal, state-regulated psilocybin services.
Open to diverse cohorts of leaders nationwide · Applications reviewed on a rolling basis
Those who lead need a place to be nourished
Faith and environmental leaders, nonprofit directors, public servants, and social justice organizers carry sustained contact with grief, trauma, injustice, often holding the weight of others' needs. They serve as stabilizing figures for entire communities, often with few places where they themselves can be supported for their own time of visioning, creativity, and healing. This lack of tending often results in burnout, moral injury, and creative stagnation.
The CLR Fund was created to give back to our community leaders through fully sponsored psilocybin retreats, providing restorative space for their own renewal while also tending to the overwhelm and psycho-spiritual challenges that come with uplifting community health.
Upcoming retreat dates
A single application covers every open retreat. Choose the one that suits you best, or rank several. Sharing more than one option helps us find you a place.
2026
2027
Apply at least six weeks before the date of the retreat you hope to attend. Applications are reviewed on a rolling basis.
Past retreats
The arc of the container
Grants support small cohorts of leaders who move through the full arc of a retreat together, including preparation, guided psilocybin sessions, and integration, all held by licensed facilitators.
1:1 Intake & Preparation
Each participant will have an individual meeting with a licensed facilitator to assess readiness and prepare for the journey ahead.
Group Preparation
For each cohort, there are two group preparation calls with fellow peers and facilitators in advance of the retreat.
The Retreat
A multi-day retreat at Fernlove, where you and your cohort will stay on site, including 1–2 guided psilocybin sessions, home-cooked organic meals together, as well as time to rest in nature.
Group Integration
In the weeks after the retreat, there will be a group integration call to process the experience. Ongoing integration calls will be available with leaders across all cohorts.
Preparation covers orientation, safety, expectations, intentions, group agreements, logistics, and space for any questions you may have.
Who can apply
- You're a community leader in a nonprofit, religious life, public service, the arts, climate/environment, or social justice
- 21 or older
- New to psilocybin or experienced (both are welcome)
- Able to meet the health & safety criteria (see FAQ)
- Can travel to Oregon, where the retreats take place (you don't need to be an Oregon resident)
- Financial need is prioritized, but not required
Community leaders, 21 and older
The fund is open to leaders aged 21 and over who meet the health criteria for participating. We award grants to those new to psychedelics and to those with prior experience, with a focus on reaching those who would not otherwise have access.
Leaders without financial need are still encouraged to apply for the cohort experience and logistical support. We welcome those with financial means to support future leaders to receive this experience.
What defines a "community leader"?
Those who spend significant time guiding, supporting, and inspiring groups of individuals toward a common good. Community leaders are often sought for their wisdom and guidance, helping to shape the health and growth of their communities.
This includes, but isn't limited to, policy makers, nonprofit leaders, religious and spiritual leaders, environmental and climate leaders, leaders in the arts, healthcare, and education, and public servants.
Unsure if you qualify? Email access@sherieckert.org.
What your grant covers
Your grant is paid directly to the licensed providers, the service center, and lodging on your behalf.
✓ Included in your grant
- Licensed psilocybin facilitation, including preparation and integration
- Your guided journey at Fernlove, an Oregon state-regulated service center
- 4–5 days of group lodging arranged by CLRF, with a private room for each participant
- Community meals prepared by a local chef, preferencing local organic ingredients
- Ongoing community integration with a peer network of leaders
– What you cover
- The psilocybin itself, typically ranging between $150 and $230 total, depending on dose and number of sessions
- All travel to and from Oregon and the service center
- Additional meals or food you buy on your own
- Any additional therapy or integration services separate from the CLRF program
Commitment deposit: A $150 deposit is due three weeks before your retreat. It is fully refundable at the end of your retreat, or you may choose to donate it back to support a future participant.
Paying it forward: Your retreat is paid for through the generosity of donors and past participants. CLRF follows in the spirit of the Vipassana meditation tradition, where each course is a gift from previous students. Following your retreat, if you’d like future leaders to have a similar opportunity, you’ll be invited to give toward a future cohort. Gifting financially is one way, although we also welcome nominations for future participants or introductions to those who may wish to support the fund. Give according to your means, or not at all.
Fernlove
Nestled within 30 acres of Oregon forest, about an hour west of Portland, Fernlove offers a quiet setting for self-exploration and connection to nature.
A nature-based setting
From the session room to the guest cabins and forest trails, every space at Fernlove is designed to support self-discovery and healing within nature.
Private lodging on site
Each participant has their own private bedroom in one of the property's forest cabins, just steps away from the psilocybin service center.
Licensed
Fernlove is a legal, state-recognized psilocybin service center. It works exclusively with licensed facilitators and psilocybin from licensed manufacturers, with careful attention to comfort and safety throughout.
CLRF retreat facilitators
Every CLRF retreat is guided by licensed Oregon psilocybin facilitators. Tap a name to learn more about a given facilitator.
HF
Henry FieldsFacilitator · BIPOC Leaders (Jul 27–31, 2026) · Director of Inward Dive
Henry Fields is one of Oregon's first state-licensed psilocybin facilitators and the founder of Inward Dive Hypnosis and Intuitive Counseling. He is also the founder of The Inward Dive Fund, a nonprofit dedicated to expanding access to psychedelic support services for underserved communities, including individuals impacted by the criminal justice system. His facilitation style emphasizes deep listening, emotional honesty, nervous system awareness, and creating spaces where clients can reconnect with their own intuition, creativity, and inner authority.
Henry is especially passionate about preparation and integration, helping clients translate insight into meaningful changes in daily life and relationships. His approach differs from traditional self-improvement models focused primarily on striving or performance. Instead, he helps clients explore and gently release the tension, protective patterns, and internal constriction that can obscure the essential self.
His work is grounded in the belief that healing is not about becoming someone else, but uncovering who we are beneath years of conditioning, adaptation, and survival strategies. Inspired by Miles Davis' observation that "it takes a long time to play like yourself," Henry believes it can also take a long time to live as yourself.
Drawing from backgrounds in music, hypnosis, yoga, mindfulness, and addiction recovery, Henry brings a compassionate, non-judgmental presence to psychedelic work. Clients often describe him as deeply grounding, easy to talk to, and having a gift for helping people feel both safe and genuinely seen.
MM
Mariah MoncadaFacilitator · BIPOC Leaders (Jul 27–31, 2026)
Mariah has been sitting with mushrooms and other plant medicines for over a decade. She holds reverence for the journey, deep trust in the client's inner healing intelligence, and a peaceful presence for others in the room. Her approach is client-centered. What is most important to her is that the client feels like they are being supported in a way that feels authentic to them.
Mariah graduated with an interdisciplinary studies degree from the University of Hawaii in Community-Based Healthcare. She was lucky to study relevant coursework such as Advanced Ethnobotany, Mycology, and Psychoactive Drug Plants. She is data/research informed and also draws from her experience in ceremonial settings that she participated in while in Peru and Hawaii.
Mariah is also a mother who will bring nurturing care to your journey. She gives consideration to many aspects of safety (physical, emotional, psychological, and spiritual) to support overall wellbeing. Mariah warmly embraces people from all walks of life, welcoming all into a space of acceptance. She is honored to co-create a space with clients so they may comfortably navigate the depths of their consciousness.
OA
Oscar AlemanRetreat Assistant · BIPOC Leaders (Jul 27–31, 2026)
Oscar Aleman is a first-generation Guatemalan American, Oregon-licensed psilocybin facilitator, certified personal trainer, and educator based in the Portland area. His work is guided by a deep interest in human growth, healing, and the connection between mental, emotional, and physical well-being.
Oscar completed his facilitator training through InnerTrek, one of Oregon's pioneering state-approved psilocybin training programs. Drawing from backgrounds in fitness coaching, education, and psychedelic facilitation, he brings a grounded, compassionate, and participant-centered approach to his work.
As the son of Guatemalan immigrants, Oscar values the importance of community, resilience, and increased accessibility. He is passionate about creating spaces where people feel safe to explore meaningful experiences, reconnect with themselves, and integrate insights into lasting positive change.
DK
David KahlFacilitator · LGBTQ+ Leaders (Aug 31–Sep 4, 2026)
David Kahl is an executive coach, Oregon-licensed psilocybin facilitator, entrepreneur, and retreat leader. Before moving into this work, he spent more than two decades building businesses, including founding Fully, a company that grew from a startup into one of the largest digital furniture brands in the world before being acquired by Herman Miller in 2019.
Today, David works with leaders and individuals from a wide range of backgrounds through coaching, facilitation, and retreat experiences. His style is warm, grounded, and direct. He is less interested in offering answers than in creating the conditions where people can discover their own.
As a gay man, David knows firsthand that many LGBTQ+ people have spent parts of their lives learning how to adapt, fit in, stay safe, or manage the expectations of others. While those experiences can build resilience and strength, they can also leave us feeling disconnected from ourselves or from one another. Because of that, he cares deeply about creating spaces where people can show up more fully as they are.
For David, one of the most meaningful aspects of retreat work is the opportunity to heal and grow in community. While each participant brings their own story, there is something powerful about gathering with others who understand, at least in part, what it means to move through the world as LGBTQ+ people. His hope is that participants leave feeling more connected: to themselves, to one another, and to what matters most in their lives.
MM
MEgan MoseleyFacilitator · LGBTQ+ Leaders (Aug 31–Sep 4, 2026)
MEgan believes healing isn't a destination, it's a homecoming you keep choosing. She is the founder of Bodywise and creator of the BE ME Framework, a somatic roadmap to your authentic self. Weaving 36 years of experience in physical therapy, somatic psychology (Hakomi, IFS, RCS), and TRE® (Trauma Release Exercise), she brings a steady, attuned presence to facilitation, and a body-mind approach to preparation and integration. Her work empowers clients to tap their body's innate wisdom, cultivate the felt sense of safety to open to the medicine, the internal resource to meet what arises, and the embodied grounding to carry it into real, lived change.
LS
Lisa SnyderRetreat Assistant · LGBTQ+ Leaders (Aug 31–Sep 4, 2026)
Lisa Snyder is a state-licensed psilocybin facilitator in Oregon (and a natural-medicine facilitator in Colorado) and the founder of Liberadiate, offering trauma-informed psilocybin journeys and integration support.
A graduate of InnerTrek, the nation's first state-approved facilitator school, Lisa brings more than eighteen years of community building and healing advocacy to her work. Her path into this field began in her twenties after losing both parents to cancer, an experience that shaped her devotion to helping others find meaning in life's hardest moments.
She specializes in supporting people navigating grief, burnout, self-doubt, and life transitions, and works especially with LGBTQ+ adults, women, creatives, entrepreneurs, and neurodivergent individuals exploring authenticity and belonging. Her work is rooted in compassion, curiosity, and the courage to turn inward.
DE
Danilo EscobarFacilitator · Christian Leaders (Nov 16–20, 2026)
Danilo Escobar is an Oregon state-licensed psilocybin facilitator, educator, healthcare administrator, and musician. For more than a decade he has worked across the healthcare system, spanning psychiatry, behavioral health, mental health, and holistic medicine.
He offers legally regulated psilocybin facilitation for individuals, couples, and groups, along with microdosing support, ceremony, retreats, and workshops. His practice is grounded in a trauma-informed, culturally rich, and person-centered approach, creating safe and supportive containers for healing, self-discovery, and growth.
KL
Kelly LundeFacilitator · Christian Leaders (Sep 14–18 and Nov 16–20, 2026)
Kelly is a somatic practitioner and artist rooted in relationship to the abundant medicine and intelligence of the natural world. As a psilocybin facilitator, she sees her work primarily as helping individuals remember who they are on the deepest levels of the body, psyche and soul.
She has sat with and alongside elders and medicine carriers around the world for over a decade. She continues to study and evolve her own spiritual practices inspired by personal Celtic and South Slavic ancestry, while in active apprenticeship with teachers who emerge from and carry traditional medicines of the Andean region. With a background in multiple somatic trauma resolution modalities, her work often orients around early imprints and developmental trauma, survivorship, LGBTQIA+ communities and those facing end of life.
As a musician, she is forever in awe of the power of sound and song to speak to the heart and heal across many dimensions. She values presence, attunement, compassion and humor among the many other, somewhat unusual traits that it takes to be good at this work.
AJ
Allyssa JomeiRetreat Assistant · Christian Leaders (Sep 14–18, 2026)
Allyssa Jomei is an interfaith spiritual director and community builder devoted to creating spaces where people can encounter themselves, one another, the Earth, and the Sacred with honesty, curiosity, and compassion. Her work draws from contemplative Christianity, Zen, neuroscience, trauma-informed care, and the wisdom of the natural world.
Rather than offering easy answers, she invites people into practices of deep listening, embodied presence, and wonder. Whether holding space in spiritual direction, or gathering people around a shared table or campfire, Allyssa believes healing and transformation emerge through authentic relationship, curiosity, compassion and faithfulness in the Mystery that is always inviting us deeper.
WC
Wendy CliffRetreat Assistant · Christian Leaders (Nov 16–20, 2026) · Interfaith Chaplain
Wendy Cliff is an Interfaith Chaplain who's served in hospitals, retirement communities, a state prison, hospice, and trained & supported mentors in the foster care system. She holds a Certificate in Trauma and Spiritual Care that guides her work serving people who live with the impacts of various personal, collective, and environmental traumas. She's a graduate of Seminary of the Wild's two-year program where she immersed herself in environmentally based spirituality and practices. Her Master of Divinity and identity as an Episcopal priest are not enacted in traditional church settings, but are rather related to her love of how story, ritual, and tangible things can bring us closer to mystery and meaning. Serving on the board of an interfaith council in the Bay Area was one of the favorite roles she's ever had. A graduate of U.C. Berkeley's Center for the Science of Psychedelics facilitator training program, she's currently doing group and individual eco-spiritual direction sessions with people wanting to incorporate practices with the natural world in their spiritual journeys.
TS
Tal SharabiFacilitator · Jewish Leaders (Jul 13–17 and Oct 19–23, 2026)
Tal Sharabi is a Licensed Professional Counselor (Oregon and Colorado) and one of the first cohort of state-licensed psilocybin facilitators in the country, she went on to teach the first class of government-licensed facilitators in the United States.
Through her practice, Interbeing Psychotherapy, she weaves together somatic, mindfulness-based, and trauma-attuned approaches, holding space at the pace each person's nervous system needs. A graduate of CIIS's Psychedelic-Assisted Therapies program and trained in MDMA-assisted therapy through MAPS and in Sensorimotor Psychotherapy, Tal brings more than two decades of mindfulness practice and a deep reverence for community, the earth, and the interconnection of all beings.
She was a featured speaker at TEDxPortland 2025 and serves as a lead educator at InnerTrek.
SM
Seth MehrFacilitator · Jewish Leaders (Jul 13–17 and Oct 19–23, 2026)
Seth Mehr, M.D., is a state-licensed psilocybin facilitator and the founder of Cascade Psychedelic Medicine. Board-certified in Emergency Medicine, he spent two decades as an emergency physician, with deep experience in medical and psychiatric emergencies and the safe administration of medicine, before dedicating himself to psychedelic care.
He served as the Health & Safety Director for InnerTrek's psilocybin service center and is a study physician on a clinical trial of MDMA-assisted therapy for social anxiety. Seth came to this work after traditional treatments failed a member of his own family, and he brings particular attention to individualized medical safety, preparation, and care.
KP
Keri PadonRetreat Assistant · Jewish Leaders (Jul 13–17 and Oct 19–23, 2026) · CLRF Program Manager
Keri Padon pairs somatic wisdom with expertise in psychedelic care. Her toolkit includes breath-led movement, nonviolent communication, and restorative justice practices that support nervous system regulation and help maintain equanimity. Warm, organized, and culturally attuned, Keri is a wonderful and foundational member of the Community Leaders Resilience Fund team.
A trauma-informed yoga teacher (E-RYT 200) and graduate of InnerTrek's Psychedelic Facilitation Training program, Keri managed the InnerTrek Service Center throughout its tenure, supporting facilitators and safeguarding client journeys. She now serves as Program Manager for the Community Leaders Resilience Fund.
What leaders have shared
Themes that surfaced repeatedly across our 2025 cohorts.
Emotional Relief
Many described releasing long-held stress, grief, and shame, processing content that years of therapy could not reach.
Renewed Purpose
Leaders spoke of greater clarity about their work, a reduced sense of hopelessness, and a renewed relationship with service.
Allowing Suffering
By touching into their own emotional process, many learned to trust and give space for the suffering of others, interrupting ongoing cycles of burnout.
Spiritual Reconnection
Many participants described a sense of sacredness in the experience through which they felt support, belonging, and the source of their leadership.
Community & Belonging
For many, the cohort itself became part of the medicine. Shared vulnerability created lasting bonds across fields of practice.
Hope in Hard Times
Leaders felt a restored sense of optimism that extended beyond naïve hope into a grounded return to possibility, faith, and agency.
In their own words
“I no longer feel moments of deep aloneness or loss.”Religious Leader
“I feel grateful for my job, perhaps for the first time.”Religious Leader
“Demoralization became action.”Local Government
“I truly believe the deeper I go, the deeper I can go with my clients and in with folks in the community.”Nonprofit and Religious Leader
“Against all evidence, I have great hope for the world, and my place in it.”Religious Leader
A first year, in numbers
Sectors represented: Faith & Spirituality · Nonprofit & Social Justice · Public Service · Arts & Culture · Environmental & Climate
What psilocybin is, and what the research suggests
A short, evidence-based primer. Tap any box to read more.
Psilocybin is a naturally occurring psychedelic compound produced by more than 200 species of mushrooms,20 several of which have been used in Indigenous healing ceremonies for centuries.12 Psilocybin is converted in the body to psilocin, which closely resembles the neurotransmitter serotonin, acting mainly as a 5-HT2A receptor agonist. This activity is thought to underlie its effects on perception, mood, and thought, contributing to its possible therapeutic effects.1 In clinical settings, psilocybin is usually only administered one or two times, catalyzing deep introspective or meditative states that may lead to enduring positive changes.




What the trials showRandomized trials show large, lasting reductions in depression and anxiety scores, in many cases lasting months to years.
In randomized trials, psilocybin-assisted therapy has been shown to produce large, durable reductions in depression and anxiety among people with life-threatening cancer,5,6,14 and significant antidepressant effects in individuals with major depressive disorder.7,15 A 233-person phase 2b trial found a single 25 mg dose eased symptoms associated with treatment-resistant depression at three weeks.8 The FDA has granted psilocybin therapy "Breakthrough Therapy" designation as a treatment for depression.13 In studies of healthy volunteers16 and religious leaders,17 most participants rated their psilocybin experience as among the most meaningful and spiritually significant of their lives, with lasting increases in well-being up to 16 months later.
How it works in the brainIt appears to increase neuroplasticity and produce more flexible brain networks.
Researchers do not yet have one complete explanation for how psilocybin elicits positive change, but several possible mechanisms have been identified: psilocybin appears to promote neuroplasticity,3 temporarily reducing activity in the brain's "default mode network" (a set of regions linked to self-focused thinking, mind-wandering, and rumination),2 helping to increase cognitive flexibility and loosening rigid patterns of thought.4 Psilocybin may help soften psychological defenses, allowing for emotional catharsis and processing of trauma or other difficult memories.18 Psilocybin and other psychedelics may also occasion "mystical-type" experiences,1,19 allowing participants to connect to something felt as sacred and beyond one's ordinary sense of self.
Why a group settingGroup preparation adds peer support, cohesion, and shared meaning.
Modern psilocybin care pairs dosing with preparation and integration, increasingly in group settings. The first modern clinical trial of psilocybin-assisted group therapy, with demoralized long-term AIDS survivors, delivered group preparation and integration (with one-to-one dosing) and found meaningful, sustained relief, with participants citing peer support playing an important role in combatting feelings of isolation and shame.9 Group "therapeutic factors" such as cohesion and shared experience may be amplified in this work,10 echoing how these medicines have long been used communally in traditional and Indigenous contexts.12
In screened, supervised settings psilocybin has a favorable physical-safety profile and is not considered addictive; the principal risks are psychological, which is exactly why screening, preparation, and trained facilitation matter.11 Psilocybin remains a federally illegal Schedule I substance, but is legal within state-regulated programs in Oregon (enacted 2020) and Colorado; New Mexico legalized access in 2025. CLRF retreats take place entirely within Oregon's licensed system.
References20 peer-reviewed and official sources, tap to view.
- Nichols DE. (2016). Psychedelics. Pharmacological Reviews, 68(2):264–355. doi.org/10.1124/pr.115.011478
- Carhart-Harris RL, et al. (2012). Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin. PNAS, 109(6):2138–2143. doi.org/10.1073/pnas.1119598109
- Shao L-X, et al. (2021). Psilocybin induces rapid and persistent growth of dendritic spines in frontal cortex in vivo. Neuron, 109(16):2535–2544. doi.org/10.1016/j.neuron.2021.06.008
- Doss MK, et al. (2021). Psilocybin therapy increases cognitive and neural flexibility in patients with major depressive disorder. Translational Psychiatry, 11:574. doi.org/10.1038/s41398-021-01706-y
- Griffiths RR, et al. (2016). Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: a randomized double-blind trial. J. Psychopharmacology, 30(12):1181–1197. doi.org/10.1177/0269881116675513
- Ross S, et al. (2016). Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial. J. Psychopharmacology, 30(12):1165–1180. doi.org/10.1177/0269881116675512
- Davis AK, et al. (2021). Effects of psilocybin-assisted therapy on major depressive disorder: a randomized clinical trial. JAMA Psychiatry, 78(5):481–489. doi.org/10.1001/jamapsychiatry.2020.3285
- Goodwin GM, et al. (2022). Single-dose psilocybin for a treatment-resistant episode of major depression. New England Journal of Medicine, 387(18):1637–1648. doi.org/10.1056/NEJMoa2206443
- Anderson BT, et al. (2020). Psilocybin-assisted group therapy for demoralized older long-term AIDS survivor men: an open-label safety and feasibility pilot study. EClinicalMedicine (Lancet), 27:100538. doi.org/10.1016/j.eclinm.2020.100538
- Ponomarenko P, et al. (2023). Can psychedelics enhance group psychotherapy? A discussion on the therapeutic factors. J. Psychopharmacology, 37(7):660–678. doi.org/10.1177/02698811231155117
- Johnson MW, Richards WA, Griffiths RR. (2008). Human hallucinogen research: guidelines for safety. J. Psychopharmacology, 22(6):603–620. doi.org/10.1177/0269881108093587
- Schultes RE. (1969). Hallucinogens of plant origin. Science, 163(3864):245–254. doi.org/10.1126/science.163.3864.245
- U.S. FDA "Breakthrough Therapy" designation for psilocybin therapy for treatment-resistant depression (COMPASS Pathways, 2018); a second designation for major depressive disorder followed (Usona Institute, 2019). compasspathways.com
- Agin-Liebes GI, et al. (2020). Long-term follow-up of psilocybin-assisted psychotherapy for psychiatric and existential distress in patients with life-threatening cancer. J. Psychopharmacology, 34(2):155–166. doi.org/10.1177/0269881119897615
- Gukasyan N, et al. (2022). Efficacy and safety of psilocybin-assisted treatment for major depressive disorder: prospective 12-month follow-up. J. Psychopharmacology, 36(2):151–158. doi.org/10.1177/02698811211073759
- Griffiths RR, et al. (2008). Mystical-type experiences occasioned by psilocybin mediate the attribution of personal meaning and spiritual significance 14 months later. J. Psychopharmacology, 22(6):621–632. doi.org/10.1177/0269881108094300
- Griffiths RR, et al. (2025). Effects of psilocybin on religious and spiritual attitudes and behaviors in clergy from various major world religions. Psychedelic Medicine, 3(4):172–191. doi.org/10.1089/psymed.2023.0044
- Swift TC, et al. (2017). Cancer at the dinner table: experiences of psilocybin-assisted psychotherapy for the treatment of cancer-related distress. J. Humanistic Psychology, 57(5):488–519. doi.org/10.1177/0022167817715966
- Griffiths RR, et al. (2006). Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance. Psychopharmacology, 187(3):268–283. doi.org/10.1007/s00213-006-0457-5
- Oregon Psilocybin Advisory Board. (2021). Rapid evidence review and recommendations. Oregon Health Authority, July 30, 2021; addendum May 5, 2025. oregon.gov
This summary is educational and is not medical advice. Psilocybin is not right for everyone; eligibility and safety are determined together with licensed professionals.
If you take the time to explore yourself, to listen to your spirit, to walk among the many less frequented paths within your mind, I am sure you will be amazed at the mesmerizing beauty you will find.Sheri Eckert
Find your way in
Whether you are an enrolled participant, a facilitator, or just exploring, there is a door for you. Tap through to the right place.
Participant guide
If you have been awarded a grant, your participant hub holds everything you'll need for your cohort, from preparation to logistics, what to expect, and how to prepare yourself for your retreat week.
Facilitator hub & field manual
Licensed facilitators and Community Stewards working with the fund have a dedicated online hub and field manual detailing the cohort model, your role, and how to hold preparation and integration.
Grantee resources
New to all this? The grantee resources page explains Oregon's legal, state-regulated psilocybin services model, now live in Colorado and coming to New Mexico, plus how psilocybin therapy works in the context of healthcare.
Frequently asked questions
While research reveals a strong safety profile, psilocybin is not for everyone. Some health conditions and situations can be unsafe, and each facilitator or service center sets its own screening criteria. The following may mean that psilocybin isn't recommended for you:
- Mental-health conditions such as schizophrenia, schizoaffective or schizophreniform disorder, major depressive disorder with psychotic features, psychotic disorder, bipolar disorder, mania, delusional disorder, any dissociative disorder, substance-induced psychosis, or severe paranoia
- Current drug or alcohol withdrawal, or active/severe drug or alcohol misuse
- Cardiovascular conditions such as poorly controlled high blood pressure, prolonged QTc interval, congestive heart failure, history of cardiac arrest or ventricular arrhythmia, presence of an AICD, coronary artery disease, angina, tachycardia, arrhythmia, Wolff-Parkinson-White syndrome, heart-valve disease or artificial valve, cardiac hypertrophy, cardiomyopathy, aortic disease, or aneurysms
- Gastrointestinal conditions such as moderate-to-severe liver impairment or gastric outlet obstruction
- Dialysis or severe kidney disease
- Neurologic conditions such as dementia, cognitive impairment, seizure disorders, epilepsy, history of stroke or TIA, or cerebral aneurysm
- Medications such as lithium, two or more medications affecting serotonin (e.g. SSRI, SNRI, SPARI, TCA, MAOI), or angle-closure glaucoma medication
- Pregnancy
- Tuberculosis, COVID, and other highly contagious diseases
- A first-degree relative (parent, sibling, child) with schizophrenia, bipolar disorder, or any psychotic or dissociative disorder
If any of these apply to you and cannot be resolved before receiving services, we encourage you to consider carefully whether to apply, as a licensed facilitator is unlikely to be able to work with you. Under Oregon law, a person cannot receive psilocybin if they have active psychosis, have taken lithium within the past 30 days, or have thoughts of harming themselves or others.
Our role is to decide whether an applicant is a good fit for a grant, not whether they should receive psilocybin. That decision is made by the licensed facilitator together with each participant.
In 2020, Oregon voters passed Ballot Measure 109 (the Oregon Psilocybin Services Act), allowing the manufacture, delivery, and administration of psilocybin within licensed service centers supervised by licensed facilitators. In 2022, Colorado became the second state to establish a regulated access program for psilocybin and related psychoactive plants.
While psilocybin is legal within the Oregon and Colorado state-regulated models, it remains a federally illegal Schedule I substance under the Controlled Substances Act.
Grants are awarded on a rolling basis and paid directly to the licensed providers, service center, and lodging on your behalf.
The grant includes: licensed facilitation, including preparation and integration; your guided journey at Fernlove, an Oregon state-regulated service center; 4–5 days of on-site lodging, with a private bedroom in one of Fernlove's forest cabins; and community meals prepared by a local chef.
You cover: the cost of the psilocybin itself (typically $150–$230 in total, depending mainly on dose); travel to and from Oregon and the service center, plus any additional travel around the state; solo meals or individually purchased food; and any additional therapy or integration services after the program. There is also a $150 commitment deposit, due three weeks before your retreat. It is fully refundable at the end of the retreat, or you can choose to donate it back to support a future participant.
Lodging is on site at Fernlove. Each participant has their own private bedroom in one of the property's forest cabins, just steps away from the service center, so you can rest and integrate without leaving the land. Lodging for the cohort is arranged by CLRF and included in your grant.
The fund supports small groups of leaders undergoing facilitation together. Cohorts may be formed by participants from shared backgrounds or be grouped by reviewers for fit. The group model fosters peer support and ongoing community connection, and allows the fund to support more leaders. If you'd prefer individual care, you can say so in your application and requests will be considered case by case.
Group work has become less common in the U.S., partly due to a Western, FDA-driven approach to psychedelic-assisted care which has centered on one-on-one models. But psychedelics, especially psilocybin, have a long history of use in group settings, both in clinical research and in Indigenous ceremonies that go back centuries.
Research suggests that feeling part of a community supports psychological wellbeing and connectedness. In our experience, many participants who initially preferred individual work end up strongly valuing the group after experiencing it. Learn more about the research on group psilocybin sessions.
Grants are awarded on a rolling basis, and we contact all applicants by email. Selection is based primarily on:
- Your work as a community leader
- Your financial need
- Your expressed need for psychological, emotional, or spiritual support, or relief from burnout
- Whether you belong to an underserved population, for example your social location in relation to geography, race, ethnicity, cultural barriers, occupation, ability, age, gender, etc.
- Your readiness to take part in psilocybin services
The CLR Fund is an initiative of the Sheri Eckert Foundation (SEF), a 501(c)(3) nonprofit committed to making Oregon and Colorado's evolving psychedelic ecosystem accessible to people of diverse backgrounds, means, and geographies.
SEF's Board of Directors includes David Bronner, Tom Eckert, Dr. Adie Rae, and Nathan Howard. Nathan Howard also serves as Executive Director, and Lorena Dame directs the CLR Fund. Magical Teams supports administration and the application process.
The State of Oregon's official Oregon Psilocybin Services page contains many resources, including sample forms like the Informed Consent and Client Bill of Rights.
You can also read the OPS Fact Sheet and the Scientific Literature Review.
Anything you share is strictly confidential. We share relevant information only with SEF staff, facilitators, and your retreat cohort leaders, as needed to run the program. Beyond that, we won't share your information with anyone without your written or electronic permission, unless required by law. Answering any question is voluntary, and choosing not to answer won't affect how your application is treated.
SEF uses your information only to review, manage, and execute the fund's program. It may be stored on secure platforms and accessed by SEF staff and contractors for that purpose. All SEF workstations are fully encrypted, and applications are collected through Typeform, which follows HIPAA-compliant data-protection standards. We do not share, sell, or lease your personal information to third parties.
Support the leaders your community leans on
The CLR Fund is supported entirely by donations, so the number of grants we're able to offer depends on the gifts we receive. Your support helps another community leader find rest, perspective, and renewed purpose.
© 2026 Sheri Eckert Foundation, a 501(c)(3) nonprofit project. Questions? access@sherieckert.org
Psilocybin is legal within state-regulated programs in Oregon and Colorado; New Mexico legalized access in 2025. It remains a federally illegal Schedule I substance. This page is informational and is not medical, legal, or financial advice. The CLR Fund determines fit for a grant; the decision to provide services rests with licensed facilitators and clients.
A letter from a rabbi in their late 70s
This letter arrived in early August 2026, addressed to a member of our team. The writer received a Community Leaders Resilience Fund grant and sat with a cohort of seven rabbis at our organized retreat in 2026.
August 2, 2026
I am writing to thank you for making possible the extraordinary experience that I, along with six other rabbis from around the country, had because of the support of the Sheri Eckert Foundation.
As I approached 50 years in the rabbinate (I was ordained in 1976) I became aware of a growing spiritual emptiness, perhaps because of the constant pull of obligations from my congregation that got in the way of my own spiritual growth, or perhaps the lack of resources I had to reignite the spark of Divinity that had drawn me into the rabbinate in the first place. A year after my retirement I heard of a program organized at Johns Hopkins for clergy that would reflect on the impact of psilocybin on the way they pastored their congregations. I leapt at the opportunity to participate because it appeared to offer a safe container for what would be, for me, a new adventure. But unfortunately, I was rejected. It seemed that the study was only interested in clergy who were currently pastoring a congregation and would go back to that same congregation. I made my best case that they reconsider, since as a retired rabbi I still have a deep connection with my congregation and with other Jewish communities that evolved out of my congregational work. But I was not accepted.
When I heard about the work Shefa was doing from some colleagues who had been in that study, I jumped at the chance to be a participant. It was the gift I had longed for: a safe container that would give me the chance to explore parts of my soul that had been closing down. I was intrigued by the thoughtful planning: while the actual ceremonies with the magic mushroom were central, there was even more time dedicated to preparation and to integration. And with the support of your foundation I was able to afford to participate.
The cohort of seven rabbis included Orthodox, Conservative, Reconstructionist, and me, Reform. We came from all over the country, women and men, younger and older (me!). Though our ways of practicing Judaism were very different, what brought us together wasn’t the size of our communities or our standing in the Jewish world but rather the longing we each had to reawaken our sense of gratitude and wonder. Each of the facilitators brought a profoundly Jewish heart and an astonishing ability to really listen to us. The Ecuadorian Miriku led the ceremonies with skill and wisdom that he channeled from his ancestors. The combination of the Jewish and the Chachi traditions was amazing.
My experience on the magic mushrooms was mind boggling and heart opening. For the first ceremony I chose a relatively low dose because it was my first experience of any psychedelic, plant based or synthetic. I saw colors I had never seen before. I went outside to see the forest close up and I actually saw the trees and flowers growing. I felt safe because of the skill and gentleness of the facilitators, as well as all the work we had done in advance to prepare for the ceremony. The second day I asked for the biggest dosage possible. That day the experience was overwhelming. I felt a sense of immense gratitude for the life I had been gifted and for the community of friends and family that had accompanied me throughout my life. I actually became a little girl again in my childhood bedroom, playing with my girl cousins, looking out the window to the house across the street where my best friend lived. I saw my parents, both of whom had died over the past ten years, and got to thank them for loving me unconditionally. And my brothers and my grandparents, and even the two-year-old sister who had died before I was born. I had never “met” her before. The journey continued throughout the different stages of my life: middle school, high school, college, my semester in Israel on the kibbutz, my rabbinical school experience in Israel and then in the US, my first job as a Hillel director, my years running a civil rights organization in LA, and my years as a congregational rabbi. I was actually there, really present with so many of the people who had been part of my life. I got to thank them and to receive their gratitude. I spent time with my beloved late husband, and was grateful to learn from him that he has encouraged me to continue to move forward to new adventures.
I stood up as the journey continued, supported by one of the facilitators. As he held me up I asked him to dance. And we did, twirling around with me screaming in delight “I can dance! Look at me, I am dancing!” And then: “And listen to me!” I (who never thought I could carry a tune) was yelling “And I can sing! Listen, I can sing!” I was ecstatic. And I felt a joy I hadn’t felt for a long time because of the crushing sense of despair about the world and my inability to manage all the pain my congregants were sharing with me and expected me to make everything better. I feel as though the journey enabled me to know that I can hold both joy and pain, celebration and loss, and even learn something from the gifts each present to me.
There is so much more to say. Perhaps one day we’ll meet and I can learn more about how you came to understand that this journey would be transformative not only to individual clergy but also, through them and the cohorts that follow, a journey that really could change the world.
With so much gratitude,
The writer is a rabbi in their late 70s, ordained in 1976, and was a CLRF grant recipient and retreat participant in the summer of 2026. Shefa, named in the letter, is the retreat partner that hosted their cohort.
Tap anywhere outside the letter to close it
2027 dates are live
The 2027 retreats are on this page, February through October, and applications are open.
Apply for a GrantSee the dates






